Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Hematology

How to Manage Teen Beta-Thalassemia Treatment Burnout

At a Glance

Teenagers with beta-thalassemia major often experience treatment burnout, scanxiety, and depression from lifelong transfusions and iron chelation. Caregivers can help by validating their feelings, fostering independence in disease management, and seeking specialized therapies like CBT or ACT.

In this answer

3 sections

01

Understanding Treatment Fatigue, Needle Exhaustion, and “Scanxiety”

02

Fostering Independence and Transitioning Care

03

Actionable Strategies for Mental Health

Watching your teenager navigate the mental health impact and treatment burnout of beta-thalassemia major is incredibly difficult. Managing this exhaustion requires a collaborative, multidisciplinary approach that goes beyond medical interventions. By acknowledging the heavy burden of endless blood transfusions and iron chelation, validating their anxiety around monitoring scans, and gradually fostering their independence in care, you can help protect their quality of life. Integrating specialized psychological support and connecting with disease-specific support networks are key strategies to improve their coping mechanisms and resilience.

Understanding Treatment Fatigue, Needle Exhaustion, and “Scanxiety”

The lifelong demands of transfusion therapy, iron chelation, and frequent hospital visits are primary drivers of treatment fatigue in teenagers with beta-thalassemia major [1][2][3]. This burden can lead to treatment burnout, which sometimes presents as missed medication doses or resistance to medical appointments [1][2]. This exhaustion is often compounded by the physical realities of the disease: the severe anemia causes physical fatigue that worsens mental burnout, while bone changes and the daily reminder of treatment can make teens grieve the “normal” life their peers enjoy. Furthermore, different chelation methods—such as the daily burden of oral tablets versus the physical discomfort of prolonged subcutaneous infusion pumps—add layers of complexity and frustration, alongside the inevitable “needle fatigue” from lifelong blood draws and transfusions.

Another common challenge is scanxiety—anxiety related to medical imaging, such as the MRI T2* scans used to monitor iron overload in the heart and liver [4][5]. Scanxiety is multi-faceted: it involves both fear of the procedure itself (like claustrophobia or loud noises) and the dread of what the results might reveal about their organ health [4][6]. Research shows that simple methods can significantly reduce this pre-scan anxiety without needing medication [7]. Effective strategies include:

  • Providing clear, tailored preparation guides, such as educational leaflets or video clips, before the scan [7][8].
  • Matching the type of preparation (e.g., informational vs. relaxation-focused) to your teen’s specific coping style [9].
  • Requesting “mock” MRI sessions to familiarize your teen with the environment and minimize the need for sedation [5][10].

Fostering Independence and Transitioning Care

As your teenager approaches adulthood, the transition from a pediatric hematologist to an adult care clinic can be daunting. Research indicates that this transition is often poorly structured, which can lead to a drop in treatment adherence and a rise in anxiety [11][12]. A critical component of a successful transition is building your teenager’s self-efficacy—their confidence in managing their own health [13].

  • Partnership in Care: Adopt a collaborative model that involves your teen in decision-making, shifting them from passive compliance to an active partner in their healthcare [14].
  • Shared Responsibility: Encourage your teen to take on manageable tasks to build confidence, such as setting their own alarms for iron chelation therapy, tracking their hemoglobin levels, or speaking directly to the nurses during transfusions [13].
  • Structured Transition: Ensure there is a clear, written transition pathway. Discuss this with your pediatric care team well before your teen moves to adult services to ensure continuity of care [11][12].

Actionable Strategies for Mental Health

Adolescents with thalassemia face significant psychological challenges, including body image concerns related to bone changes, social stigma, and an increased risk of depression. Routine psychological screening is essential [15][16][17].

  • Specialized Therapy: Chronic-illness specialized psychotherapies, particularly Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT), are evidence-based methods that improve psychological flexibility and reduce disease-related distress [18][19][20]. ACT, for example, helps patients manage chronic symptoms and anxiety through values-based action and cognitive defusion (learning to detach from unhelpful thoughts rather than fighting them) [21][22].
  • Emotional Intelligence Training: Interventions focusing on emotional awareness have shown promise in improving how teens cope with the unique stressors of thalassemia [23].
  • Support Groups: Group-based psychosocial interventions and disease-specific support networks—such as the Cooley’s Anemia Foundation—provide essential social backing. Connecting with peers who truly understand the burden of chronic care reduces isolation, normalizes their struggles, and offers therapeutic benefits that improve health-related quality of life [24][25][26].

Common questions in this guide

Why do teens with beta-thalassemia struggle with treatment burnout?
The lifelong demands of transfusion therapy, daily iron chelation, and frequent hospital visits cause severe treatment fatigue. This exhaustion, combined with physical fatigue and grief over losing a 'normal' teenage life, can lead to missed medications or skipped appointments.
What is scanxiety in beta-thalassemia?
Scanxiety refers to the fear and dread associated with medical imaging, such as the MRI T2* scans used to monitor iron overload. It includes fear of the loud, claustrophobic MRI machine as well as deep anxiety about what the test results might reveal about their organ health.
How can I help my teenager overcome beta-thalassemia treatment fatigue?
You can help by validating their frustration, fostering their independence in managing their care, and shifting them into an active partnership role. Specialized mental health therapies and disease-specific support groups can also build essential resilience.
What mental health therapies help teens cope with beta-thalassemia?
Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) are highly effective for teens with chronic illnesses. These therapies help them manage disease-related distress, anxiety, and the daily burden of medical treatments.
How do I prepare my teen to transition to adult thalassemia care?
Start building their self-efficacy early by having them manage small tasks, like tracking hemoglobin levels or speaking directly to nurses. Work with your pediatric team to create a structured, written transition pathway well before they move to an adult clinic.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does our clinic have a dedicated transition coordinator or a formal, step-by-step plan for moving my teen to adult care?
  2. 2.Can we arrange a 'mock MRI' or a tour of the imaging facility before their next T2* scan to help reduce their scanxiety?
  3. 3.Are there alternative iron chelation delivery methods we could explore if my teen is experiencing severe treatment fatigue with their current regimen?
  4. 4.Can you recommend a mental health professional who specializes in chronic illness and is familiar with therapies like CBT or ACT?
  5. 5.How often does your clinic conduct routine psychological or depression screening for adolescents?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

New Meds to Reduce Beta-Thalassemia Transfusions?Does Beta-Thalassemia Major Affect Growth & Puberty?Does Beta-Thalassemia Gene Therapy Cause Infertility?Why Does Beta-Thalassemia Cause Bone & Facial Changes?How Do Zynteglo & Casgevy Work for Beta-Thalassemia?Chances of Beta-Thalassemia Major for Carrier ParentsWhat Happens If You Miss Iron Chelation Doses?What Is a Cardiac T2* MRI for Thalassemia?How Much Do Zynteglo and Casgevy Gene Therapies Cost?What Is the Life Expectancy for Beta-Thalassemia Major?What is the Pesaro Score for Stem Cell Transplants?Why Do You Need Vision & Hearing Exams With Chelation?Why Do Beta-Thalassemia Symptoms Start at 3-6 Months?Why is Spleen Removal Needed for Beta-Thalassemia?

References

References (26)
  1. 1

    Drug-related problems among transfusion-dependent thalassemia patients: A real-world evidence study.

    Chun GY, Mohd Tahir NA, Islahudin F, et al.

    Frontiers in pharmacology 2023; (14()):1128887 doi:10.3389/fphar.2023.1128887.

    PMID: 37153805
  2. 2

    Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study.

    Chun GY, Ng SSM, Islahudin F, et al.

    International journal of clinical pharmacy 2024; (46(3)):736-744 doi:10.1007/s11096-024-01716-y.

    PMID: 38551751
  3. 3

    Evidence for multidimensional resilience in adult patients with transfusion-dependent thalassemias: Is it more common than we think?

    Almahmoud SY, Coifman KG, Ross GS, et al.

    Transfusion medicine (Oxford, England) 2016; (26(3)):186-94 doi:10.1111/tme.12296.

    PMID: 27018402
  4. 4

    Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions.

    Derry-Vick HM, Heathcote LC, Glesby N, et al.

    Cancers 2023; (15(5)) doi:10.3390/cancers15051381.

    PMID: 36900174
  5. 5

    Key considerations for child and adolescent MRI data collection.

    Davis BR, Garza A, Church JA

    Frontiers in neuroimaging 2022; (1()) doi:10.3389/fnimg.2022.981947.

    PMID: 36312216
  6. 6

    Assessment of Anxiety Associated With MRI Examination Among the General Population in the Western Region of Saudi Arabia.

    Al Shanbari NM, Alobaidi SF, Alhasawi R, et al.

    Cureus 2023; (15(2)):e34531 doi:10.7759/cureus.34531.

    PMID: 36874299
  7. 7

    Survey of maternal anxiety and perceptions towards foetal MRI and pre-scan education.

    Plunkett S, Dobeli K, Prior M, Tusek X

    Journal of medical radiation sciences 2024; (71(1)):10-20 doi:10.1002/jmrs.725.

    PMID: 37724764
  8. 8

    The experience of patients participating in a small randomised control trial that explored two different interventions to reduce anxiety prior to an MRI scan.

    Tugwell-Allsup J, Pritchard AW

    Radiography (London, England : 1995) 2018; (24(2)):130-136 doi:10.1016/j.radi.2017.11.001.

    PMID: 29605109
  9. 9

    Preparing patients according to their individual coping style improves patient experience of magnetic resonance imaging.

    Madl JEM, Sturmbauer SC, Janka R, et al.

    Journal of behavioral medicine 2022; (45(6)):841-854 doi:10.1007/s10865-022-00361-y.

    PMID: 36074316
  10. 10

    Evaluating Sedation Strategies for Magnetic Resonance Imaging: A Comprehensive Review of Intravenous Fentanyl, Butorphanol, and Midazolam in Adult and Pediatric Populations.

    Verma N, Dahake JS

    Cureus 2024; (16(4)):e58593 doi:10.7759/cureus.58593.

    PMID: 38770500
  11. 11

    Transition from Pediatric to Adult Care in Patients with Transfusion-Dependent Beta-Thalassemia in France: A National Study Concerning a Rare Disease.

    Szepetowski S, Benoit A, Berbis J, et al.

    Journal of clinical medicine 2026; (15(6)) doi:10.3390/jcm15062203.

    PMID: 41899126
  12. 12

    Thalassaemia-A global view.

    Hokland P, Daar S, Khair W, et al.

    British journal of haematology 2023; (201(2)):199-214 doi:10.1111/bjh.18671.

    PMID: 36799486
  13. 13

    Development and Psychometric Assessment of "Self-Efficacy Scale" for Patients With Beta Thalassemia Major: A Mixed-Methods Study.

    Narenjbaghi SH, Valizadeh L, Zamanzadeh V, et al.

    Journal of nursing measurement 2025; (33(1)):48-61 doi:10.1891/JNM-2023-0080.

    PMID: 38519072
  14. 14

    The Effect of Partnership Care Model on Mental Health of Patients with Thalassemia Major.

    Shamsi A, Amiri F, Ebadi A, Ghaderi M

    Depression research and treatment 2017; (2017()):3685402 doi:10.1155/2017/3685402.

    PMID: 28713591
  15. 15

    Body image issues and self-concept dilemmas in adolescents living with thalassemia.

    Dhawan M, N T S, Kakkar S

    Psychology, health & medicine 2022; (27(3)):598-612 doi:10.1080/13548506.2021.1903050.

    PMID: 33784896
  16. 16

    Psychological Burden and Suicidal Vulnerability in Adolescents with Thalassemia Major: A Scoping Review.

    Mardhiyah A, Yosep I, Pahria T, Yamin A

    Journal of multidisciplinary healthcare 2026; (19()):589598 doi:10.2147/JMDH.S589598.

    PMID: 41836878
  17. 17

    Prevalence of Depression among Iranian Patients with Beta-Thalassemia Major: A Systematic Review and Meta-analysis.

    Jaafari Z, Sadidi N, Abdolahinia Z, Shahesmaeili A

    Iranian journal of medical sciences 2022; (47(1)):15-24 doi:10.30476/ijms.2020.85941.1557.

    PMID: 35017773
  18. 18

    Optimizing psychological treatments for pediatric chronic pain to enhance outcomes, availability, and accessibility.

    Pielech M, Beckmann EA, Dorsainvil H

    Current opinion in psychology 2025; (64()):102038 doi:10.1016/j.copsyc.2025.102038.

    PMID: 40156988
  19. 19

    Effects of Acceptance and Commitment Therapy on health-related outcomes for patients with advanced cancer: A systematic review.

    Li H, Wong CL, Jin X, et al.

    International journal of nursing studies 2021; (115()):103876 doi:10.1016/j.ijnurstu.2021.103876.

    PMID: 33517079
  20. 20

    Conducting Outcomes Research in a Clinical Practice Setting: The Effectiveness and Acceptability of Acceptance and Commitment Therapy (ACT) in a Partial Hospital Program.

    Morgan TA, Dalrymple K, D'Avanzato C, et al.

    Behavior therapy 2021; (52(2)):272-285 doi:10.1016/j.beth.2020.08.004.

    PMID: 33622499
  21. 21

    Acceptance and Commitment Therapy for Primary Headache Sufferers: A Randomized Controlled Trial of Efficacy.

    Vasiliou VS, Karademas EC, Christou Y, et al.

    The journal of pain 2021; (22(2)):143-160 doi:10.1016/j.jpain.2020.06.006.

    PMID: 32682815
  22. 22

    Acceptance and commitment therapy for psychosis: Current status, lingering questions and future directions.

    Morris EMJ, Johns LC, Gaudiano BA

    Psychology and psychotherapy 2024; (97(1)):41-58 doi:10.1111/papt.12479.

    PMID: 37357973
  23. 23

    The effect of applying emotional intelligence components on coping strategies in adolescents with beta-thalassemia major: a randomized clinical trial.

    Ahmadian B, Ramezani M, Badiei Z, Vaghee S

    BMC pediatrics 2024; (24(1)):591 doi:10.1186/s12887-024-05057-7.

    PMID: 39289663
  24. 24

    Acceptance and commitment-based therapy for patients with psychiatric and physical health conditions in routine general hospital care - Development, implementation and outcomes.

    Burian H, Böge K, Burian R, et al.

    Journal of psychosomatic research 2021; (143()):110374 doi:10.1016/j.jpsychores.2021.110374.

    PMID: 33571859
  25. 25

    An evaluation of an open group for depressed mood on a stroke rehabilitation ward: three years of clinical data.

    Blake J, Beazley P, Steverson T

    Disability and rehabilitation 2024; (46(5)):939-946 doi:10.1080/09638288.2023.2186498.

    PMID: 36916395
  26. 26

    Brief group-based acceptance and commitment therapy for stroke survivors.

    Majumdar S, Morris R

    The British journal of clinical psychology 2019; (58(1)):70-90 doi:10.1111/bjc.12198.

    PMID: 29999185

This page is for educational purposes to help caregivers support teens with beta-thalassemia. It is not a substitute for professional medical advice or psychiatric care. Always consult your healthcare team.

Get notified when new evidence is published on Beta-thalassemia major.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.